相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion-positive solid tumors
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma
Casey J. N. Mathison et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer
Connor O'Leary et al.
CANCERS (2019)
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
Lois M. Mulligan
FRONTIERS IN PHYSIOLOGY (2019)
Targeting RET-rearranged non-small-cell lung cancer: future prospects
Giuseppe Bronte et al.
LUNG CANCER-TARGETS AND THERAPY (2019)
Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers
Robert Roskoski et al.
PHARMACOLOGICAL RESEARCH (2018)
Precision Targeted Therapy with BLU-667 for RET-Driven Cancers
Vivek Subbiah et al.
CANCER DISCOVERY (2018)
RET kinase inhibitors: a review of recent patents (2012-2015)
Luca Mologni et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
LOXO-292, a Potent, Highly Selective RET Inhibitor, in MKI-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases
V. Velcheti et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Progress in Discovery of KIF5B-RET Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer
Minsoo Song
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Tyrosine kinase gene rearrangements in epithelial malignancies
Alice T. Shaw et al.
NATURE REVIEWS CANCER (2013)
The receptor tyrosine kinase RET regulates hindgut colonization by sacral neural crest cells
Jean-Marie Delalande et al.
DEVELOPMENTAL BIOLOGY (2008)
Gini coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases
Piotr P. Graczyk
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Ba/F3 cells and their use in kinase drug discovery
Markus Warmuth et al.
CURRENT OPINION IN ONCOLOGY (2007)
7-alkyl- and 7-cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines -: potent inhibitors of the tyrosine kinase c-Src
L Widler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
分享论文
